The IC50 values of oxaliplatin in the control andJUNB-knockdown AGS-OR cells were measured, and the IC50 values were significantly reduced whenJUNB was silenced (Figure 3D), which implied that a high level of JUNB confers oxaliplatin resistance in GC. The gene discussed is JUNB; the disease is gastric cancer.